Venetoclax to Augment Epigenetic Modification and Chemotherapy

Clinical trial NCT05317403 · RECRUITING

Trial details

NCT number: NCT05317403
Sponsor: Medical College of Wisconsin
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia Refractory

Start date: 2023-03-31
Primary completion: 2027-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.